MSDS for Antibodies

Material Safety Data Sheet (MSDS) for Antibodies

I. Identification:

Product name: Antibodies
Product Catalog Number: Includes antibodies within the following range of catalog numbers: 00001-90000.

CAS number: None

Manufacturer Supplier: BiCell Scientific Inc, 11466 Schenk Drive, St louis, MO 63043

II. Composition/Information on Ingredients:

This product is composed of antibodies in aqueous buffer solution. According to 29 CFR 1910.1200 (d), hazardous ingredients at less than <1% and carcinogens at less than < 0.1% are considered non-hazardous. Any hazardous or carcinogenic ingredients exceeding these criteria are listed below.

This product may contain the following hazardous ingredients.

Ingredient: Sodium azide; CAS#: 26628-22-8; Percent: 0.1%

III. Hazard Identification:

Emergency Overview of Hazardous ingredient: Sodium azide (CAS# 26628-22-8)

Caution: Avoid contact, ingestion and inhalation.
Target Organ: Kidneys, liver, skin.

NFPA Rating: Health Rating: 1; Flammability Rating: 0 Reactivity Rating: 0

IV. First Aid Measures:

Inhalation: If inhaled, remove to fresh air. If breathing is difficult, get medical attention.

Ingestion: If swallowed and person is conscious, rinse out mouth with water. Get medical attention.

Skin Exposure: In case of contact, wash skin with soap and water.

Eye Exposure: In case of contact with eyes, immediately flush eyes water for at least 15 minutes. Get medical attention.

V. Fire Fighting Measures:

Flash Point: Data not available.

Autoignition Temperature: Data not available.

Fire Extinguishing Media: Water spray, dry chemical, foam, or carbon dioxide.

Firefighting: Wear protective clothing and self-contained breathing apparatus to prevent contact with skin and eyes.

VI. Accidental Release Measures:

Absorb liquid with an absorbent material. Transfer contaminated absorbent to a chemical waste container for disposal.

VII. Handling and Storage:

Avoid inhalation and contact with eyes and skin. Avoid prolonged or repeated exposure. Store at –20°C in tightly closed container.

VIII. Exposure Controls/Personal

Engineering Controls: Maintain adequate ventilation, eye wash and quick-drench facilities in work area.

Personal Protective Equipment: Lab coat, chemical resistant gloves and chemical safety glasses.

Occupational Exposure Limits: Data not available.

IX. Exposure Controls/Personal Protection:

Physical State: Colorless liquid.
Odor: Odorless.
Boiling Point: Data not available.
Melting Point: Data not available.
Volatile Organic Compound: Data not available.

Solubility in water: Readily miscible in water.

X. Stability and Reactivity:

Stability: Stable.
Hazardous Decomposition: May form carbon dioxide and carbon monoxide.

Conditions to avoid: Strong oxidizing agents

XI. Toxicological Information:

May cause skin irritation.
May be toxic if absorbed through skin or ingested.

May cause eye irritation.

Target Organs: Kidneys, liver, skin
Prolonged exposure may cause nausea, headache, and vomiting.

XII. Ecological Information:

Data not available.

XIII. Disposal Considerations:

Dispose of in accordance with federal, state and local environmental regulations.

XIV. Transport Information:

D.O.T.: This substance is considered non-hazardous for transport.

IATA: This substance is considered non-hazardous for air transport.

XV. Regulatory Information:

EU Regulation/Classification/Labeling Information: Not available for this product.

Chemical Inventory Status:
SARA Listed Component: None.

TSCA Listed Component: None.

Canada (WHMIS): DSL No, NDSL No.

XVI. Other Information:

This compound is sold only for research use by personnel familiar with chemicals and who are well trained in good laboratory habits, such as avoiding spills, keeping hands clean at all times and not rubbing eyes with hands while working in the laboratory. This solution is sold only in microliter quantities for use in life sciences research. No other use is intended, and any other use may involve substantive hazards.

The above information is believed to be correct but does not purport to be all inclusive and shall be used only as a guide for experienced personnel. BiCell Scientific Inc., shall not be held liable for any damage resulting from the handling of or from contact with the above product. The burden of safe use of this material rests entirely with the user.

"I am really impressed with your approach. We tried multiple times previously to create monoclonal and polyclonal antibodies to claudin-2 and MLCK1. We have had limited success generating polyclonals and no success generating monoclonals. You have generated outstanding monoclonals to both. I look forward to continuing to work with you."

Jerrold R. Turner, M.D., Ph.D.

Brigham and Women’s Hospital | Harvard Medical School

"The polyclonal antibody you generated for KIAA0408 is stunning! KIAA0408 is a novel cilium molecule that has never been studied. So, clearly there will be a lot of demand for it as we have discovered a very interesting finding and the story will be published in a high impact journal. I am strongly inclined to generate monoclonal antibody for this protein too and we should think about patenting it."

Univ.-Prof. Jay Gopalakrishnan PhD

Heinrich-Heine-Universität | Universitätsklinikum Düsseldorf

"Your ARL13B antibody works beautifully!!! We’re so happy to have a cilia-specific antibody made in rat! I can send you high resolution images to be posted on your website."

Julie Craft Van De Weghe, PhD

School of Medicine | University of Washington

"The assay is a homophilic interaction mediated cell adhesion on purified protein (in this case, immobilized purified Pcdhga9 to Pcdhga9 expressed on cell surface). Compared to control, cell adhesion is reduced in the presence of Pcdhga9 monoclonal antibody supernatants!"

Divyesh Joshi, PhD

School of Medicine | Yale University

"The rabbit hybridoma supernatants of anti-APOBEC3 project are tested positive by ELISA, and we are very happy about it! We previously tried a company, Abclone. Their Project "A" has immune response that is <10,000 titer in antiserum, which would explain why there is no positive mAb after fusion. Their project "B" didn't have any immune response in rabbit."

Harshita B Gupta, PhD.

School of Medicine | UT Health San Antonio

Contact us for questions or custom requests!